DRKS00029693已完成不适用
Baseline immunity to SARS-CoV-2 (COVID-19) in the German population. - GUIDE
Institut für Virologie/Universitätsklinikum Bonn0 个研究点目标入组 15,941 人开始时间: 2022年7月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15,941
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Randomised invitation based on participation in the payback panel
- •- Randomised invitation for participation via telephone
- •- Ability to answer a questionaire in german
排除标准
- 未提供
研究者
相似试验
招募中
不适用
SARS-CoV-2 specific immunity in persons with a primary immune deficiencyPrimary Immune DeficiencyNL-OMON24202eiden University Medical Center10
已完成
Unknown
T2B! immunity after SARS-CoV-2<p>SARS-CoV-2, auto-immune diseases,</p>10003816NL-OMON23600ZonMw3,361
招募中
不适用
Immunity against SARS-CoV-2 in immune-suppressed patients: increased risk of insufficient immunological memory or sufficient protection against re-infection? A Target to B! substudyhematologische en andere B-cel gemedieerde aandoeningenimmunityimmunosuppressive medicationSARS-CoV-2 infection1000381610047438NL-OMON55289Academisch Medisch Centrum5,350
已完成
不适用
Investigation of the immune status against SARS-CoV-2 of medical professionals in Doctor's Practices in Thuringia (COVID-19 research project)SPECIFIC METHODS OF INVESTIGATION FOR SARSCOV2COVID19 VIRUS NOT CONFIRMED COVID19 O.N.A.U99.0U07.2COVID-19, virus not identifiedDRKS00021815Kassenärztliche Vereinigung Thüringen5,773
已完成
4 期
Immunity Against COVID-19 and Safety Following Evusheld (Long-acting Antibody) in Immunocompromised Children and AdolescentsImmunocompromised Children and AdolescentsEvusheldTCTR20230406002Faculty of Medicine Siriraj Hospital, Mahidol University70